Literature DB >> 25696583

Selection of patients for ICD therapy still under debate: Contra ICD.

A R Ramdat Misier, M J de Boer, W P Beukema.   

Abstract

Entities:  

Year:  2006        PMID: 25696583      PMCID: PMC2557332     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  10 in total

1.  Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial.

Authors:  B F Uretsky; K Thygesen; P W Armstrong; J G Cleland; J D Horowitz; B M Massie; M Packer; P A Poole-Wilson; L Ryden
Journal:  Circulation       Date:  2000-08-08       Impact factor: 29.690

Review 2.  Sudden death due to cardiac arrhythmias.

Authors:  H V Huikuri; A Castellanos; R J Myerburg
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

3.  Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Authors:  Ilan Goldenberg; Arthur J Moss; Scott McNitt; Wojciech Zareba; W Jackson Hall; Mark L Andrews; David J Wilber; Helmut U Klein
Journal:  J Am Coll Cardiol       Date:  2006-04-17       Impact factor: 24.094

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

Authors:  Stefan H Hohnloser; Karl Heinz Kuck; Paul Dorian; Robin S Roberts; John R Hampton; Robert Hatala; Eric Fain; Michael Gent; Stuart J Connolly
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

6.  Association of myocardial ischemia with mortality and implantable cardioverter-defibrillator therapy in patients with coronary artery disease at risk of arrhythmic death.

Authors:  Abdou Elhendy; Scott Chapman; Thomas R Porter; John Windle
Journal:  J Am Coll Cardiol       Date:  2005-10-10       Impact factor: 24.094

7.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

8.  Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: rationale and design of the Defibrillator After Primary Angioplasty (DAPA) trial.

Authors:  Jan Paul Ottervanger; Anand R Ramdat Misier; Felix Zijlstra; Martin J Schalij; Eric Wever; Luc J L M Jordaens; Jose P S Henriques; Menko-Jan de Boer; Hindrik W J Robbe; Hein J J Wellens
Journal:  Am Heart J       Date:  2006-10       Impact factor: 4.749

9.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

10.  Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death.

Authors:  Alida E Borger van der Burg; Jeroen J Bax; Eric Boersma; Ernest K J Pauwels; Ernst E van der Wall; Martin J Schalij
Journal:  Circulation       Date:  2003-10-06       Impact factor: 29.690

  10 in total
  1 in total

1.  About hearsay - or reappraisal of the role of the anamnesis as an instrument of meaningful communication.

Authors:  C van Tellingen
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.